1.
Acta Pharmaceutica Sinica B
;
(6): 3105-3119, 2021.
Article
in English
| WPRIM
| ID: wpr-922783
ABSTRACT
Pulmonary fibrosis (PF) is a chronic, progressive, fatal interstitial lung disease with limited available therapeutic strategies. We recently reported that the protein kinase glycogen synthase kinase-3